236 related articles for article (PubMed ID: 36421694)
21. Subgenomic RNA profiling suggests novel mechanism in coronavirus gene regulation and host adaption.
Lyu L; Feng R; Zhang M; Xie X; Liao Y; Zhou Y; Guo X; Su B; Dorsett Y; Chen L
Life Sci Alliance; 2022 Aug; 5(8):. PubMed ID: 35470238
[TBL] [Abstract][Full Text] [Related]
22. Overview of SARS-CoV-2 genome-encoded proteins.
Bai C; Zhong Q; Gao GF
Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
[TBL] [Abstract][Full Text] [Related]
23.
Periwal N; Bhardwaj U; Sarma S; Arora P; Sood V
Front Cell Infect Microbiol; 2022; 12():966870. PubMed ID: 36519126
[TBL] [Abstract][Full Text] [Related]
24. Molecular Characterization of SARS-CoV-2.
Dërmaku-Sopjani M; Sopjani M
Curr Mol Med; 2021; 21(7):589-595. PubMed ID: 33272175
[TBL] [Abstract][Full Text] [Related]
25. Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences.
Lee JY; Wing PAC; Gala DS; Noerenberg M; Järvelin AI; Titlow J; Zhuang X; Palmalux N; Iselin L; Thompson MK; Parton RM; Prange-Barczynska M; Wainman A; Salguero FJ; Bishop T; Agranoff D; James W; Castello A; McKeating JA; Davis I
Elife; 2022 Jan; 11():. PubMed ID: 35049501
[TBL] [Abstract][Full Text] [Related]
26. The Translational Landscape of SARS-CoV-2-infected Cells Reveals Suppression of Innate Immune Genes.
Puray-Chavez M; Lee N; Tenneti K; Wang Y; Vuong HR; Liu Y; Horani A; Huang T; Gunsten SP; Case JB; Yang W; Diamond MS; Brody SL; Dougherty J; Kutluay SB
mBio; 2022 Jun; 13(3):e0081522. PubMed ID: 35604092
[TBL] [Abstract][Full Text] [Related]
27. A high-resolution temporal atlas of the SARS-CoV-2 translatome and transcriptome.
Kim D; Kim S; Park J; Chang HR; Chang J; Ahn J; Park H; Park J; Son N; Kang G; Kim J; Kim K; Park MS; Kim YK; Baek D
Nat Commun; 2021 Aug; 12(1):5120. PubMed ID: 34433827
[TBL] [Abstract][Full Text] [Related]
28. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
[TBL] [Abstract][Full Text] [Related]
29. Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Fahnøe U; Pham LV; Fernandez-Antunez C; Costa R; Rivera-Rangel LR; Galli A; Feng S; Mikkelsen LS; Gottwein JM; Scheel TKH; Ramirez S; Bukh J
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215765
[TBL] [Abstract][Full Text] [Related]
30. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
[TBL] [Abstract][Full Text] [Related]
31. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 subgenomic RNA: formation process and rapid molecular diagnostic methods.
Ge X; Zhou H; Shen F; Yang G; Zhang Y; Zhang X; Li H
Clin Chem Lab Med; 2024 May; 62(6):1019-1028. PubMed ID: 38000044
[TBL] [Abstract][Full Text] [Related]
33. In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs.
Sun L; Li P; Ju X; Rao J; Huang W; Ren L; Zhang S; Xiong T; Xu K; Zhou X; Gong M; Miska E; Ding Q; Wang J; Zhang QC
Cell; 2021 Apr; 184(7):1865-1883.e20. PubMed ID: 33636127
[TBL] [Abstract][Full Text] [Related]
34. The emerging role of miRNAs in the pathogenesis of COVID-19: Protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection.
Yang CY; Chen YH; Liu PJ; Hu WC; Lu KC; Tsai KW
Int J Med Sci; 2022; 19(8):1340-1356. PubMed ID: 35928726
[TBL] [Abstract][Full Text] [Related]
35. Pseudoknot-targeting Cas13b combats SARS-CoV-2 infection by suppressing viral replication.
Yu D; Han HJ; Yu J; Kim J; Lee GH; Yang JH; Song BM; Tark D; Choi BS; Kang SM; Heo WD
Mol Ther; 2023 Jun; 31(6):1675-1687. PubMed ID: 36945774
[TBL] [Abstract][Full Text] [Related]
36. Comparison of viral propagation and drug response among SARS-CoV-2 VOCs using replicons capable of recapitulating virion assembly and release.
Tian L; Liu Q; Pei R; Chen Y; Xu C; Tang J; Sun H; Liu K; Yang Q; Yang L; Li L; Zhang Y; Zhou Y; Shan C; Hu X; Chen X; Wang Y
Virol Sin; 2022 Oct; 37(5):695-703. PubMed ID: 35781091
[TBL] [Abstract][Full Text] [Related]
37. A DNA-based non-infectious replicon system to study SARS-CoV-2 RNA synthesis.
Feng X; Zhang X; Jiang S; Tang Y; Cheng C; Krishna PA; Wang X; Dai J; Zeng J; Xia T; Zhao D
Comput Struct Biotechnol J; 2022; 20():5193-5202. PubMed ID: 36059866
[TBL] [Abstract][Full Text] [Related]
38. Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-19.
Casagrande M; Fitzek A; Spitzer MS; Püschel K; Glatzel M; Krasemann S; Nörz D; Lütgehetmann M; Pfefferle S; Schultheiss M
JAMA Ophthalmol; 2021 Apr; 139(4):383-388. PubMed ID: 33475692
[TBL] [Abstract][Full Text] [Related]
39. Differential Transcriptomic Landscapes of SARS-CoV-2 Variants in Multiple Organs from Infected Rhesus Macaques.
Du T; Gao C; Lu S; Liu Q; Yang Y; Yu W; Li W; Qiao Sun Y; Tang C; Wang J; Gao J; Zhang Y; Luo F; Yang Y; Yang YG; Peng X
Genomics Proteomics Bioinformatics; 2023 Oct; 21(5):1014-1029. PubMed ID: 37451436
[TBL] [Abstract][Full Text] [Related]
40. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
